In summary, these findings indicate that Curcumol facilitates HIF-1α degradation predominantly by upregulating VHL and enhancing its interaction with HIF-1α, therefore disrupting glycolytic signaling and limiting CRC progression. Here, HIF1A is linked to colorectal carcinoma.